This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Ryerson University, Sunnybrook Research Institute, The University of British Columbia. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2025
Title: Innovations of Joel Ramjist in Hydrogel Technology.
Introduction
Joel Ramjist is an innovative inventor based in Toronto, Canada. He has made significant contributions to the field of hydrogel technology, particularly in the area of in-vivo delivery systems. His work focuses on enhancing the delivery and modification of hydrogels for medical applications.
Latest Patents
Joel Ramjist holds a patent for a device titled "Hydrogel co-injection and real-time opto-electromagnetic modification device for tunable in-vivo delivery." This patent describes systems, devices, and methods that enable dynamic modification of the physicochemical properties of a hydrogel during its in-vivo formation and delivery by a catheter. The invention allows for the controlled crosslinking of a hydrogel precursor, which can be injected through an intravascular catheter. This technology is designed to ensure that the hydrogel is suitable for specific medical applications, such as embolization or drug delivery.
Career Highlights
Throughout his career, Joel has worked with prestigious institutions, including the University of British Columbia and Ryerson University. His experience in these academic environments has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Joel has collaborated with notable colleagues, including Yuta Dobashi and Jerry Ku. These partnerships have further enriched his research and development efforts in hydrogel technology.
Conclusion
Joel Ramjist's innovative work in hydrogel technology exemplifies the potential for advancements in medical delivery systems. His contributions are paving the way for more effective treatments and improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile